(DOGG) First Trust Exchange-Traded - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33738D8469 • Derivative Income

DOGG: Common Stocks, Exchange-Traded Options, Short-Term Treasury Securities

The First Trust Exchange-Traded Fund IV - FT Cboe Vest DJIA Dogs 10 Target Income ETF (BATS:DOGG) is designed to generate income while providing exposure to a concentrated portfolio of large-capitalization U.S. equity securities. Under normal market conditions, the fund primarily invests in common stocks, exchange-traded options (including Flexible EXchange options, or FLEX Options), and short-term U.S. Treasury securities. The strategy aims to deliver a consistent level of income, targeting approximately 8% (before fees and expenses) above the annualized yield of the Dow Jones Industrial Average (DJIA). The fund is non-diversified, meaning it may concentrate its holdings in a smaller number of securities, which can increase risk.

As of the latest data, the fund has an average 20-day trading volume of 21,620 shares, with a last price of $21.39. Its short-term technical indicators show the price above the 20-day simple moving average (SMA) of $20.60 but slightly above the 50-day SMA of $19.93. The 200-day SMA stands at $19.52, indicating the fund is trading near its longer-term average. The Average True Range (ATR) of 0.24 reflects relatively stable price movements. The fund manages assets under management (AUM) of $28.02 million, placing it in the smaller ETF category within the derivative income space.

Over the next three months, the funds performance will likely be influenced by its ability to maintain the targeted income level amid market conditions. Based on technical data, the funds price may consolidate near current levels, with potential upside limited by the 200-day SMA. The low ATR suggests volatility will remain muted. From a fundamental perspective, the funds AUM of $28.02 million indicates modest liquidity, which could impact trading efficiency during periods of high market stress. Overall, the fund is expected to continue its strategy of providing income with exposure to large-cap equities, with returns closely tied to the performance of the DJIA and the yield curve.

Additional Sources for DOGG ETF

DOGG ETF Overview

Market Cap in USD 34m
Category Derivative Income
TER 0.75%
IPO / Inception 2023-04-26

DOGG ETF Ratings

Growth Rating 45.3
Fundamental -
Dividend Rating 68.6
Rel. Strength -2.21
Analysts -
Fair Price Momentum 20.29 USD
Fair Price DCF -

DOGG Dividends

Dividend Yield 12m 8.78%
Yield on Cost 5y 10.07%
Annual Growth 5y 22.30%
Payout Consistency 100.0%

DOGG Growth Ratios

Growth Correlation 3m -7.4%
Growth Correlation 12m 63.4%
Growth Correlation 5y 87%
CAGR 5y 7.36%
CAGR/Max DD 5y 0.66
Sharpe Ratio 12m 0.88
Alpha -0.96
Beta 0.471
Volatility 18.23%
Current Volume 19.1k
Average Volume 20d 13.2k
What is the price of DOGG stocks?
As of April 23, 2025, the stock is trading at USD 19.52 with a total of 19,110 shares traded.
Over the past week, the price has changed by -0.95%, over one month by -5.00%, over three months by -0.81% and over the past year by +4.49%.
Is First Trust Exchange-Traded a good stock to buy?
Partly, yes. Based on ValueRay Analyses, First Trust Exchange-Traded (BATS:DOGG) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 45.27 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOGG as of April 2025 is 20.29. This means that DOGG is currently overvalued and has a potential downside of 3.94%.
Is DOGG a buy, sell or hold?
First Trust Exchange-Traded has no consensus analysts rating.
What are the forecast for DOGG stock price target?
According to ValueRays Forecast Model, DOGG First Trust Exchange-Traded will be worth about 22.1 in April 2026. The stock is currently trading at 19.52. This means that the stock has a potential upside of +13.32%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 22.1 13.3%